FDA Zantac Withdrawal: What You Need to Know

In 2019, independent tests indicated that there were unsafe levels of a cancer-causing carcinogen in Zantac and the generic forms of the medication, ranitidine. Major pharmacies all over the US began to take these medications off their shelves, and now the US Food and Drug Administration (FDA) has formally requested that manufacturers pull all of…

Read More

To Protect You From COVID-19 Tiano O’Dell, PLLC Will Remain Available Over Phone, Email and Video Conference. Learn More Here. Close